Global Hemophilia Drugs Sales Market Report 2016

November 2016 | 127 pages | ID: GE6B3CC0572EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Hemophilia Drugs

Revenue, means the sales value of Hemophilia Drugs

This report studies sales (consumption) of Hemophilia Drugs in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Baxalta
• Bayer
• CSL Behring
• Novo Nordisk
• Pfizer
• Roche
• Alnylam Pharmaceuticals
• Amarna Therapeutics
• Asklepios BioPharmaceutical
• Biogen
• BioMarin
• Catalyst Bioscience
• Chiesi Farmaceutici
• Dimension Therapeutics
• Emergent BioSolutions
• Grifols, Kedrion Biopharma
• Octapharma
• rEVO Biologics
• OPKO Biologics
• Sangamo Biosciences
• Spark Therapeutics
• Swedish Orphan Biovitrum
• UniQure Biopharma.

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Hemophilia Drugs in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Hemophilia Drugs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Hemophilia Drugs Sales Market Report 2016

1 HEMOPHILIA DRUGS OVERVIEW

1.1 Product Overview and Scope of Hemophilia Drugs
1.2 Classification of Hemophilia Drugs
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Hemophilia Drugs
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Hemophilia Drugs Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Hemophilia Drugs (2011-2021)
  1.5.1 Global Hemophilia Drugs Sales and Growth Rate (2011-2021)
  1.5.2 Global Hemophilia Drugs Revenue and Growth Rate (2011-2021)

2 GLOBAL HEMOPHILIA DRUGS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Hemophilia Drugs Market Competition by Manufacturers
  2.1.1 Global Hemophilia Drugs Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Hemophilia Drugs Revenue and Share by Manufacturers (2011-2016)
2.2 Global Hemophilia Drugs (Volume and Value) by Type
  2.2.1 Global Hemophilia Drugs Sales and Market Share by Type (2011-2016)
  2.2.2 Global Hemophilia Drugs Revenue and Market Share by Type (2011-2016)
2.3 Global Hemophilia Drugs (Volume and Value) by Regions
  2.3.1 Global Hemophilia Drugs Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Hemophilia Drugs Revenue and Market Share by Regions (2011-2016)
2.4 Global Hemophilia Drugs (Volume) by Application

3 UNITED STATES HEMOPHILIA DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Hemophilia Drugs Sales and Value (2011-2016)
  3.1.1 United States Hemophilia Drugs Sales and Growth Rate (2011-2016)
  3.1.2 United States Hemophilia Drugs Revenue and Growth Rate (2011-2016)
  3.1.3 United States Hemophilia Drugs Sales Price Trend (2011-2016)
3.2 United States Hemophilia Drugs Sales and Market Share by Manufacturers
3.3 United States Hemophilia Drugs Sales and Market Share by Type
3.4 United States Hemophilia Drugs Sales and Market Share by Application

4 CHINA HEMOPHILIA DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Hemophilia Drugs Sales and Value (2011-2016)
  4.1.1 China Hemophilia Drugs Sales and Growth Rate (2011-2016)
  4.1.2 China Hemophilia Drugs Revenue and Growth Rate (2011-2016)
  4.1.3 China Hemophilia Drugs Sales Price Trend (2011-2016)
4.2 China Hemophilia Drugs Sales and Market Share by Manufacturers
4.3 China Hemophilia Drugs Sales and Market Share by Type
4.4 China Hemophilia Drugs Sales and Market Share by Application

5 EUROPE HEMOPHILIA DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Hemophilia Drugs Sales and Value (2011-2016)
  5.1.1 Europe Hemophilia Drugs Sales and Growth Rate (2011-2016)
  5.1.2 Europe Hemophilia Drugs Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Hemophilia Drugs Sales Price Trend (2011-2016)
5.2 Europe Hemophilia Drugs Sales and Market Share by Manufacturers
5.3 Europe Hemophilia Drugs Sales and Market Share by Type
5.4 Europe Hemophilia Drugs Sales and Market Share by Application

6 JAPAN HEMOPHILIA DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Hemophilia Drugs Sales and Value (2011-2016)
  6.1.1 Japan Hemophilia Drugs Sales and Growth Rate (2011-2016)
  6.1.2 Japan Hemophilia Drugs Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Hemophilia Drugs Sales Price Trend (2011-2016)
6.2 Japan Hemophilia Drugs Sales and Market Share by Manufacturers
6.3 Japan Hemophilia Drugs Sales and Market Share by Type
6.4 Japan Hemophilia Drugs Sales and Market Share by Application

7 GLOBAL HEMOPHILIA DRUGS MANUFACTURERS ANALYSIS

7.1 Baxalta
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Hemophilia Drugs Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Baxalta Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Bayer
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 127 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Bayer Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 CSL Behring
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 143 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 CSL Behring Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Novo Nordisk
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Nov Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Novo Nordisk Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 Pfizer
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Pfizer Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Roche
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Roche Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview
7.7 Alnylam Pharmaceuticals
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Pharma & Healthcare Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Alnylam Pharmaceuticals Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.7.4 Main Business/Business Overview
7.8 Amarna Therapeutics
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Amarna Therapeutics Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.8.4 Main Business/Business Overview
7.9 Asklepios BioPharmaceutical
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Asklepios BioPharmaceutical Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.9.4 Main Business/Business Overview
7.10 Biogen
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Biogen Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.10.4 Main Business/Business Overview
7.11 BioMarin
7.12 Catalyst Bioscience
7.13 Chiesi Farmaceutici
7.14 Dimension Therapeutics
7.15 Emergent BioSolutions
7.16 Grifols, Kedrion Biopharma
7.17 Octapharma
7.18 rEVO Biologics
7.19 OPKO Biologics
7.20 Sangamo Biosciences
7.21 Spark Therapeutics
7.22 Swedish Orphan Biovitrum
7.23 UniQure Biopharma.

8 HEMOPHILIA DRUGS MAUFACTURING COST ANALYSIS

8.1 Hemophilia Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Hemophilia Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Hemophilia Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Hemophilia Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL HEMOPHILIA DRUGS MARKET FORECAST (2016-2021)

12.1 Global Hemophilia Drugs Sales, Revenue Forecast (2016-2021)
12.2 Global Hemophilia Drugs Sales Forecast by Regions (2016-2021)
12.3 Global Hemophilia Drugs Sales Forecast by Type (2016-2021)
12.4 Global Hemophilia Drugs Sales Forecast by Application (2016-2021)

13 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Hemophilia Drugs
Table Classification of Hemophilia Drugs
Figure Global Sales Market Share of Hemophilia Drugs by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Hemophilia Drugs
Figure Global Sales Market Share of Hemophilia Drugs by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Hemophilia Drugs Revenue and Growth Rate (2011-2021)
Figure China Hemophilia Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Hemophilia Drugs Revenue and Growth Rate (2011-2021)
Figure Japan Hemophilia Drugs Revenue and Growth Rate (2011-2021)
Figure Global Hemophilia Drugs Sales and Growth Rate (2011-2021)
Figure Global Hemophilia Drugs Revenue and Growth Rate (2011-2021)
Table Global Hemophilia Drugs Sales of Key Manufacturers (2011-2016)
Table Global Hemophilia Drugs Sales Share by Manufacturers (2011-2016)
Figure 2015 Hemophilia Drugs Sales Share by Manufacturers
Figure 2016 Hemophilia Drugs Sales Share by Manufacturers
Table Global Hemophilia Drugs Revenue by Manufacturers (2011-2016)
Table Global Hemophilia Drugs Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Hemophilia Drugs Revenue Share by Manufacturers
Table 2016 Global Hemophilia Drugs Revenue Share by Manufacturers
Table Global Hemophilia Drugs Sales and Market Share by Type (2011-2016)
Table Global Hemophilia Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Hemophilia Drugs by Type (2011-2016)
Figure Global Hemophilia Drugs Sales Growth Rate by Type (2011-2016)
Table Global Hemophilia Drugs Revenue and Market Share by Type (2011-2016)
Table Global Hemophilia Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Hemophilia Drugs by Type (2011-2016)
Figure Global Hemophilia Drugs Revenue Growth Rate by Type (2011-2016)
Table Global Hemophilia Drugs Sales and Market Share by Regions (2011-2016)
Table Global Hemophilia Drugs Sales Share by Regions (2011-2016)
Figure Sales Market Share of Hemophilia Drugs by Regions (2011-2016)
Figure Global Hemophilia Drugs Sales Growth Rate by Regions (2011-2016)
Table Global Hemophilia Drugs Revenue and Market Share by Regions (2011-2016)
Table Global Hemophilia Drugs Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Hemophilia Drugs by Regions (2011-2016)
Figure Global Hemophilia Drugs Revenue Growth Rate by Regions (2011-2016)
Table Global Hemophilia Drugs Sales and Market Share by Application (2011-2016)
Table Global Hemophilia Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Hemophilia Drugs by Application (2011-2016)
Figure Global Hemophilia Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Hemophilia Drugs Sales and Growth Rate (2011-2016)
Figure United States Hemophilia Drugs Revenue and Growth Rate (2011-2016)
Figure United States Hemophilia Drugs Sales Price Trend (2011-2016)
Table United States Hemophilia Drugs Sales by Manufacturers (2011-2016)
Table United States Hemophilia Drugs Market Share by Manufacturers (2011-2016)
Table United States Hemophilia Drugs Sales by Type (2011-2016)
Table United States Hemophilia Drugs Market Share by Type (2011-2016)
Table United States Hemophilia Drugs Sales by Application (2011-2016)
Table United States Hemophilia Drugs Market Share by Application (2011-2016)
Figure China Hemophilia Drugs Sales and Growth Rate (2011-2016)
Figure China Hemophilia Drugs Revenue and Growth Rate (2011-2016)
Figure China Hemophilia Drugs Sales Price Trend (2011-2016)
Table China Hemophilia Drugs Sales by Manufacturers (2011-2016)
Table China Hemophilia Drugs Market Share by Manufacturers (2011-2016)
Table China Hemophilia Drugs Sales by Type (2011-2016)
Table China Hemophilia Drugs Market Share by Type (2011-2016)
Table China Hemophilia Drugs Sales by Application (2011-2016)
Table China Hemophilia Drugs Market Share by Application (2011-2016)
Figure Europe Hemophilia Drugs Sales and Growth Rate (2011-2016)
Figure Europe Hemophilia Drugs Revenue and Growth Rate (2011-2016)
Figure Europe Hemophilia Drugs Sales Price Trend (2011-2016)
Table Europe Hemophilia Drugs Sales by Manufacturers (2011-2016)
Table Europe Hemophilia Drugs Market Share by Manufacturers (2011-2016)
Table Europe Hemophilia Drugs Sales by Type (2011-2016)
Table Europe Hemophilia Drugs Market Share by Type (2011-2016)
Table Europe Hemophilia Drugs Sales by Application (2011-2016)
Table Europe Hemophilia Drugs Market Share by Application (2011-2016)
Figure Japan Hemophilia Drugs Sales and Growth Rate (2011-2016)
Figure Japan Hemophilia Drugs Revenue and Growth Rate (2011-2016)
Figure Japan Hemophilia Drugs Sales Price Trend (2011-2016)
Table Japan Hemophilia Drugs Sales by Manufacturers (2011-2016)
Table Japan Hemophilia Drugs Market Share by Manufacturers (2011-2016)
Table Japan Hemophilia Drugs Sales by Type (2011-2016)
Table Japan Hemophilia Drugs Market Share by Type (2011-2016)
Table Japan Hemophilia Drugs Sales by Application (2011-2016)
Table Japan Hemophilia Drugs Market Share by Application (2011-2016)
Table Baxalta Basic Information List
Table Baxalta Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Baxalta Hemophilia Drugs Global Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Hemophilia Drugs Global Market Share (2011-2016)
Table CSL Behring Basic Information List
Table CSL Behring Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure CSL Behring Hemophilia Drugs Global Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novo Nordisk Hemophilia Drugs Global Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Hemophilia Drugs Global Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Hemophilia Drugs Global Market Share (2011-2016)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Alnylam Pharmaceuticals Hemophilia Drugs Global Market Share (2011-2016)
Table Amarna Therapeutics Basic Information List
Table Amarna Therapeutics Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amarna Therapeutics Hemophilia Drugs Global Market Share (2011-2016)
Table Asklepios BioPharmaceutical Basic Information List
Table Asklepios BioPharmaceutical Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Asklepios BioPharmaceutical Hemophilia Drugs Global Market Share (2011-2016)
Table Biogen Basic Information List
Table Biogen Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biogen Hemophilia Drugs Global Market Share (2011-2016)
Table BioMarin Basic Information List
Table BioMarin Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure BioMarin Hemophilia Drugs Global Market Share (2011-2016)
Table Catalyst Bioscience Basic Information List
Table Catalyst Bioscience Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Catalyst Bioscience Hemophilia Drugs Global Market Share (2011-2016)
Table Chiesi Farmaceutici Basic Information List
Table Chiesi Farmaceutici Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Chiesi Farmaceutici Hemophilia Drugs Global Market Share (2011-2016)
Table Dimension Therapeutics Basic Information List
Table Dimension Therapeutics Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Dimension Therapeutics Hemophilia Drugs Global Market Share (2011-2016)
Table Emergent BioSolutions Basic Information List
Table Emergent BioSolutions Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Emergent BioSolutions Hemophilia Drugs Global Market Share (2011-2016)
Table Grifols, Kedrion Biopharma Basic Information List
Table Grifols, Kedrion Biopharma Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Grifols, Kedrion Biopharma Hemophilia Drugs Global Market Share (2011-2016)
Table Octapharma Basic Information List
Table Octapharma Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Octapharma Hemophilia Drugs Global Market Share (2011-2016)
Table rEVO Biologics Basic Information List
Table rEVO Biologics Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure rEVO Biologics Hemophilia Drugs Global Market Share (2011-2016)
Table OPKO Biologics Basic Information List
Table OPKO Biologics Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure OPKO Biologics Hemophilia Drugs Global Market Share (2011-2016)
Table Sangamo Biosciences Basic Information List
Table Sangamo Biosciences Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sangamo Biosciences Hemophilia Drugs Global Market Share (2011-2016)
Table Spark Therapeutics Basic Information List
Table Spark Therapeutics Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Spark Therapeutics Hemophilia Drugs Global Market Share (2011-2016)
Table Swedish Orphan Biovitrum Basic Information List
Table Swedish Orphan Biovitrum Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Swedish Orphan Biovitrum Hemophilia Drugs Global Market Share (2011-2016)
Table UniQure Biopharma. Basic Information List
Table UniQure Biopharma. Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure UniQure Biopharma. Hemophilia Drugs Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hemophilia Drugs
Figure Manufacturing Process Analysis of Hemophilia Drugs
Figure Hemophilia Drugs Industrial Chain Analysis
Table Raw Materials Sources of Hemophilia Drugs Major Manufacturers in 2015
Table Major Buyers of Hemophilia Drugs
Table Distributors/Traders List
Figure Global Hemophilia Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Global Hemophilia Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Hemophilia Drugs Sales Forecast by Regions (2016-2021)
Table Global Hemophilia Drugs Sales Forecast by Type (2016-2021)
Table Global Hemophilia Drugs Sales Forecast by Application (2016-2021)